Search alternatives:
point decrease » point increase (Expand Search)
mg decrease » _ decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
50 mg » 10 mg (Expand Search)
point decrease » point increase (Expand Search)
mg decrease » _ decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
50 mg » 10 mg (Expand Search)
-
15381
Data_Sheet_1_Epidemiological Consequences of Viral Interference: A Mathematical Modeling Study of Two Interacting Viruses.PDF
Published 2022“…We find that population-level effect of viral block is a decrease in the number of people infected with the suppressed virus. …”
-
15382
S1 Data -
Published 2024“…The two groups of rats were observed and compared for PVT formation at 1, 3 and 5 days after modeling, respectively.</p><p>Results</p><p>A stable rat PVT model was successfully constructed. …”
-
15383
-
15384
-
15385
-
15386
-
15387
Table 5_Soybean yield, nutrient use efficiency, and economic returns of phosphorus and potassium in Ghana’s interior savanna.docx
Published 2024“…The PFP, AE, and VCR values decreased with increasing P and K rates, with the greatest PFP, AE, and VCR from T5 (P25K0) at Manga and Dokpong and T2 (P0K25) at Nyankpala. …”
-
15388
DataSheet1_Cytokine production in an ex vivo model of SARS-CoV-2 lung infection.pdf
Published 2024“…We developed a novel ex vivo model of SARS-CoV-2 infection of lung explants, that maintains the intact tissue composition and the viral load for up to 7–10 days. …”
-
15389
-
15390
-
15391
-
15392
Adverse events in low-dose naltrexone arm.
Published 2024“…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”
-
15393
CONSORT flow diagram.
Published 2024“…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”
-
15394
Adverse events in placebo arm.
Published 2024“…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”
-
15395
Adverse events in gabapentin arm.
Published 2024“…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”
-
15396
Dot1a represses Aqp5 mRNA expression in mouse cortical collecting duct M1 and mouse lung epithelial MLE-15 cells.
Published 2013“…<p>(<b>A–B</b>) Real-time RT-qPCR showing that siRNA-mediated depletion of Dot1la in M1 cells increases endogenous Aqp5 expression (<b>A</b>) and that overexpression of Dot1a decreases endogenous Aqp5 expression in MLE-15 cells (<b>B</b>). …”
-
15397
-
15398
-
15399
-
15400